Cellectar Biosciences

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$0
$0
$0
$330
Gross Profit
-66
260
EBITDA
-12,676
-13,259
-12,477
EBIT
-12,744
-13,327
-12,547
Net Income
-2,355
-14,664
-919
-7,448
Net Change In Cash
0
0
0
330
Free Cash Flow
-10,974
-9,166
-14,162
-9,862
Cash
23,288
34,263
25,868
9,564
Basic Shares
37,143
39,794
35,848
18,609

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-192
-192
-238
-227
EBITDA
-51,777
-38,768
-28,665
-23,981
EBIT
-38,960
-38,960
-28,813
-24,131
Net Income
-44,581
-37,983
-28,601
-23,970
Net Change In Cash
0
0
0
0
Free Cash Flow
-47,687
-33,241
-25,448
-22,710
Cash
23,288
9,564
19,866
35,703
Basic Shares
37,143
12,221
7,055
5,551

Earnings Calls

Quarter EPS
2024-12-31
-$0.01
2024-09-30
-$0.37
2024-06-30
-$0.03
2024-03-31
-$0.74